FRANCISCO JAVIER
BALLESTEROS RODRIGUEZ
PROFESORADO TITULAR DE UNIVERSIDAD
![Foto de FRANCISCO JAVIER](/img/nophoto.png)
![Foto de Hospital Universitario Araba](/img/noimage_org.png)
Hospital Universitario Araba
Vitoria, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Araba (12)
2021
2012
-
Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful
Histopathology, Vol. 60, Núm. 5, pp. 785-792
2011
-
Cognitive performance and smoking in first-episode psychosis: The self-medication hypothesis
European Archives of Psychiatry and Clinical Neuroscience, Vol. 261, Núm. 4, pp. 241-250
2008
-
THE ROLE OF TRYPTOPHAN HYDROXYLASE 2 (TPH-2) GENE POLYMORPHISMS IN THE PATHOGENESIS OF COMPLETED SUICIDE
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
-
Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders
Acta Psychiatrica Scandinavica, Vol. 117, Núm. 3, pp. 207-215
2003
-
Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depresión
Medicina Clinica, Vol. 120, Núm. 18, pp. 693-700
-
Principal components of mania
Journal of Affective Disorders, Vol. 76, Núm. 1-3, pp. 95-102
1998
-
First episode in bipolar disorder: Misdiagnosis and psychotic symptoms
Journal of Affective Disorders, Vol. 50, Núm. 1, pp. 41-44
1997
-
Predictores de rehospitalización en la esquizofrenia
Actas Espanolas de Psiquiatria, Vol. 25, Núm. 4, pp. 217-224
1995
-
Retention rates in two naltrexone programmes for heroin addicts in Vitoria, Spain
European Psychiatry, Vol. 10, Núm. 4, pp. 183-188
1994
-
Factors associated with utilization of hospital emergency services by alcoholic patients in a follow-up study of 18 months
Medicina clínica, Vol. 102, Núm. 18, pp. 694-698
1992
-
Naltrexone maintenance programs for heroin addicts: retention rates in Vitoria (Spain)
European Neuropsychopharmacology, Vol. 2, Núm. 3, pp. 333